Stock OSI PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News OSI Pharmaceuticals, Inc.

Equities

US6710401034

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for OSI Pharmaceuticals, Inc.

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
OSI PHARM : Astellas Completes Acquisition of OSI Pharmaceuticals
PR
OSI PHARM : Astellas Announces Successful Completion of Tender Offer for Shares of OSI
PR
OSI PHARM : OSI Pharmaceuticals Announces Occurrence of a Fundamental Change for Convertible Notes
BU
OSI PHARM : Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period
PR
OSI PHARM : Expiration Date of OSI Offer Extended to June 2, 2010
PR
OSI PHARM : Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
PR
OSI PHARM : Expiration Date of OSI Offer Extended to May 17, 2010
PR
OSI PHARM : Expiration Date of OSI Offer Extended to April 23, 2010
PR
OSI PHARM : Astellas Signs Confidentiality Agreement With OSI
PR
OSI PHARM : Astellas Announces Changes to Director Nominees for Election to OSI Pharmaceuticals' Board of Directors
PR
OSI PHARM : Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals' 2010 Annual Stockholders Meeting
PR
OSI PHARM : Astellas Responds to OSI Pharmaceuticals' Rejection
PR
OSI PHARM : Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals for $52 per Share in Cash
PR
OSI PHARM : Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
PR
OSI PHARMACEUTICAL : Seven Summits Research Releases Comments on MRK, PNC, SNDK, TYC, and OSIP
PR
Osi Pharmaceuticals : OSI Pharmaceuticals to Present at the UBS Global Life Sciences Conference on Wednesday, September 26, 2007
BU
Osi Pharmaceuticals : OSI Pharmaceuticals Announces Patent Term Extension for Tarceva(R) (erlotinib)
BU
Osi Pharmaceuticals : OSI Pharmaceuticals Summarizes Data Presented on Tarceva(R) (erlotinib) at the 12th World Congress on Lung Cancer Meeting
BU
Osi Pharmaceuticals : OSI Pharmaceuticals Announces Positive Results from a Metformin Drug Interaction Study with Its DP-IV Inhibitor, PSN9301
BU
Osi Pharmaceuticals : OSI Pharmaceuticals Announces Second Quarter 2007 Financial Results
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News OSI Pharmaceuticals, Inc.